/A
Active, not recruiting
- Conditions
- MedDRA version: 14.1Level: LLTClassification code 10034633Term: Peripheral vascular diseaseSystem Organ Class: 10047065 - Vascular disordersTherapeutic area: Diseases [C] - Cardiovascular Diseases [C14]
- Registration Number
- EUCTR2011-005111-91-FR
- Lead Sponsor
- CHU de Clermont-Ferrand
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Not Recruiting
- Sex
- All
- Target Recruitment
- Not specified
Inclusion Criteria
Are the trial subjects under 18? no
Number of subjects for this age range:
F.1.2 Adults (18-64 years) yes
F.1.2.1 Number of subjects for this age range
F.1.3 Elderly (>=65 years) yes
F.1.3.1 Number of subjects for this age range
Exclusion Criteria
Not provided
Study & Design
- Study Type
- Interventional clinical trial of medicinal product
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Main Objective: ;Secondary Objective: ;Primary end point(s):
- Secondary Outcome Measures
Name Time Method
Related Research Topics
Explore scientific publications, clinical data analysis, treatment approaches, and expert-compiled information related to the mechanisms and outcomes of this trial. Click any topic for comprehensive research insights.
What molecular mechanisms of curcumin are relevant to peripheral vascular disease pathophysiology?
How does curcumin compare to standard-of-care treatments for vascular disorders in clinical trials?
Are there specific biomarkers that predict curcumin response in peripheral vascular disease patients?
What are the potential adverse events associated with curcumin therapy in vascular diseases?
What combination therapies involving curcumin show promise for treating peripheral vascular disease?